Watchlist Price Alert

Sio Gene Therapies Inc. (SIOX)

NASDAQ: SIOX · Real-Time Price · USD

0.48

0.09 (23.14%)

At close: Feb 07, 2024, 8:58 PM

Sio Gene Therapies Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-29.58M	-50.41M	-68.46M	-71.84M	-70.77M	-55.93M	-44.28M	-42.2M	-46.04M	-49.11M	-51.45M	-69.17M	-66.42M	-85.16M	-105.4M	-127.02M	-137.75M	-160.72M	-197.26M	-213.32M	-242.37M	-234.97M	-207.82M	-180.5M	-157.99M	-172.57M	-143.09M	-133.16M	-102.58M	-40.02M	-27.98M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-28.55M	-49.98M	-68.14M	-71.63M	-61.83M	-47.08M	-35.97M	-32.64M	-45.76M	-49.11M	-52.73M	-72.19M	-64.96M	-85.16M	-105.14M	-128.93M	-145.15M	-168.78M	-205.72M	-220.65M	-249.91M	-240M	-210.85M	-182.01M	-157.99M	-172.57M	-143.09M	-133.16M	-102.58M	-40.02M	-27.98M
Net Income	-28.16M	-50.2M	-68.42M	-71.89M	-61.89M	-46.95M	-35.7M	-32.42M	-45.74M	-49.27M	-53.16M	-72.63M	-65.03M	-85.28M	-105.23M	-129.06M	-145.34M	-168.94M	-204.19M	-221.57M	-249.09M	-239M	-212.16M	-180.95M	-157.79M	-173.33M	-143.14M	-133.15M	-103.47M	-40.12M	-28.06M
Selling & General & Admin	9M	10.49M	17.3M	18.16M	21.66M	21.77M	16.51M	17.29M	18.46M	19.67M	20.23M	22.06M	23.09M	28.61M	34.18M	39.47M	35.55M	42.65M	62.14M	71.91M	81.96M	75.27M	54.61M	45.72M	40.58M	57.46M	51.77M	56.52M	49.37M	21.14M	17.38M
Research & Development	20.37M	39.77M	50.88M	53.4M	49.04M	34.16M	27.77M	24.9M	27.58M	29.44M	31.21M	47.11M	43.34M	56.55M	71.22M	87.55M	102.2M	118.06M	135.12M	141.41M	160.41M	159.69M	153.21M	134.78M	117.42M	115.11M	91.31M	76.64M	53.21M	18.89M	10.61M
Other Expenses	832K	292K	65K	-39K	8.88M	8.86M	8.31M	10.36M	1.51M	2.31M	2.33M	1.36M	7.12M	6.51M	7.38M	5.62M	260K	-368K	-814K	211K	-693K	47.83M	89.48M	127.03M	127.4M	141.98M	100.46M	62.55M	62.55M	n/a	n/a
Operating Expenses	29.37M	50.26M	68.18M	71.56M	70.69M	55.93M	44.28M	42.2M	46.04M	49.11M	51.45M	69.17M	66.42M	85.16M	105.4M	127.02M	137.75M	160.72M	197.26M	213.32M	242.37M	234.97M	207.82M	180.5M	157.99M	172.57M	143.09M	133.16M	102.58M	40.02M	27.98M
Interest Expense	8K	15K	26K	27K	20K	14K	4K	799K	1.24M	2.3M	3.62M	4.38M	5.66M	6.5M	7.12M	7.53M	7.65M	7.7M	7.64M	7.54M	6.84M	4.89M	3.02M	1.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	29.37M	50.26M	68.18M	71.56M	70.69M	55.93M	44.28M	42.2M	46.04M	49.11M	51.45M	69.17M	66.42M	85.16M	105.4M	127.02M	137.75M	160.72M	197.26M	213.32M	242.37M	234.97M	207.82M	180.5M	157.99M	172.57M	143.09M	133.16M	102.58M	40.02M	27.98M
Income Tax Expense	-381K	151K	195K	171K	-24K	-143K	-270K	-212K	-22K	157K	430K	438K	65K	126K	93K	133K	192K	164K	-1.52M	921K	-823K	-1.01M	1.31M	-1.06M	-202K	761K	56K	-18K	900K	98K	74K
Shares Outstanding (Basic)	73.98M	73.98M	73.77M	73.71M	73.34M	72.94M	72.86M	65.98M	52.68M	46.73M	43.29M	25M	22.79M	22.78M	22.78M	19.96M	16.1M	15.11M	13.47M	13.46M	13.46M	13.45M	13.3M	12.4M	12.4M	12.4M	12.39M	12.39M	12.39M	12.39M	10.04M
Shares Outstanding (Diluted)	73.98M	73.98M	73.77M	73.71M	73.34M	72.94M	72.86M	66.25M	52.68M	46.73M	43.29M	25M	22.79M	22.78M	22.78M	19.96M	16.1M	15.11M	13.47M	13.46M	13.46M	13.45M	13.3M	12.4M	12.4M	12.4M	12.39M	12.39M	12.39M	12.39M	10.04M
EPS (Basic)	-0.38	-0.68	-0.93	-0.98	-0.85	-0.7	-0.62	-0.66	-1.28	-1.7	-2.1	-3.13	-2.91	-4.42	-6.05	-8.67	-10.1	-12.27	-15.17	-16.53	-18.91	-18.47	-16.74	-14.6	-12.73	-13.98	-11.54	-11.27	-8.88	-3.77	-2.8
EPS (Diluted)	-0.38	-0.68	-0.93	-0.98	-0.85	-0.7	-0.62	-0.66	-1.28	-1.7	-2.1	-3.13	-2.91	-4.42	-6.05	-8.67	-10.1	-12.27	-15.17	-16.53	-18.91	-18.47	-16.74	-14.6	-12.73	-13.98	-11.54	-11.27	-8.88	-3.77	-2.8
EBITDA	-13.03M	-38.28M	-59.4M	-71.19M	-61.39M	-46.84M	-35.23M	-30.3M	-42.27M	-43.7M	-34.19M	-53.01M	-45.21M	-65.42M	-96.61M	-119.75M	-134.88M	-157.41M	-194.29M	-210.02M	-240.95M	-234.05M	-207.49M	-180.84M	-157.96M	-172.56M	-143.06M	-133.15M	-102.56M	-40.01M	-27.98M
EBIT	-13.03M	-38.55M	-59.76M	-71.66M	-53.19M	-38.37M	-27.28M	-23.15M	-43.96M	-46.24M	-47.24M	-65.93M	-50.7M	-70.06M	-90.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	524K	581K	827K	666K	705K	1.15M	1.66M	2.47M	2.89M	3.11M	3.22M	3.09M	2.71M	2.33M	2.21M	2.45M	3.09M	3.68M	3.78M	3.08M	2.33M	1.28M	573K	249K	41K	22K	24K	14K	8K	14K	1K